Compositions and methods for cancer treatment include mixtures of antineoplastic agents, including chemotherapeutic agents produced by classified animals and one or more nucleic acid molecules, which can negatively affect the characterization of carcinogenesis. Not all IG20 gene conjugation variants except Ig20 are negatively regulated. In one implementation, the paired variant of Ig20 is Madd, while the nucleic acid molecule is Siam.RNHC and Oligodeoxyribonucleic acid are complements to the nucleic acid sequence of foreign 13L adds or RNM converters of foreign 13L adds. Treatment of cancer, combined with comprehensive treatment of nucleic acid molecules, can negatively regulate precursors.At least one Ig20 gene conjugation pressure and a taxonomic chemotherapeutic agent. Requirement 1: Combination of anticancer agents for cancer treatment is characterized by the presence of an effective number of one or more nucleic acid molecules that can reduce the expression of at least one cutting variant and the binding of Ig20 genes.Here, all forms of IG20 cleavage and adhesion are expressed, along with one or more taxonomic derivatives of chemotherapy. Proposition 3: The combination of Proposition 2 is characterized by assertion 2 having at least one cutting variant and IG20 pairing as the intermediate and intermediate variants displayed by external factor 13L. Nucleic acid molecules selected from RNA PI have at least one cleavage variant and Ig20 gene conjugation.Arnhp and Oligonucleic Acid 7. Requirement 7: The combination of Requirement 6 is characterized by the fact that RNAPI and RNHP are composed of a structured nucleic acid molecule X 83478 3378345； 83488305； 7496； (833888305-X83368345)； 834883838305478345； (83488383838383838383838305)； 7496833838；X consists of or basically consists of CGCAATCTATCATC (SEQ ID No.1) nucleic acid sequences. Claim 14: The combination of claim 1 is characterized by the selection of one or more Taxano derivatives from Paclitaxel, Docetaxel,
